“…This finding is in line with previous reports although different measurement methods were used to quantify the Neurocrit Care degree of CA impairment [1,23,24]. Patients with an unfavorable clinical course showed an early deterioration of ARI-values at day 2 after the initial bleeding with demonstration of a significant negative trend from day 1 until day 8 with significantly lower ARI-values compared to the group with a favorable clinical outcome.…”
Early deterioration of CA significantly correlates with unfavorable clinical outcome and severity of angiographic vasospasm. Dynamic CA measurements might represent an important tool in stratifying therapy guidelines in patients after SAH.
“…This finding is in line with previous reports although different measurement methods were used to quantify the Neurocrit Care degree of CA impairment [1,23,24]. Patients with an unfavorable clinical course showed an early deterioration of ARI-values at day 2 after the initial bleeding with demonstration of a significant negative trend from day 1 until day 8 with significantly lower ARI-values compared to the group with a favorable clinical outcome.…”
Early deterioration of CA significantly correlates with unfavorable clinical outcome and severity of angiographic vasospasm. Dynamic CA measurements might represent an important tool in stratifying therapy guidelines in patients after SAH.
“…The ARI has shown good reliability compared to other static indices 22,23 and proofed good reproducibility under physiological and pathophysiological conditions including SAH. 4,7,15,17 There are hints in previous literature that there seems to be an early divergence between dynamic CA courses of patients with VS/delayed infarcts and patients with an unremarkable radiological course. 7 These findings are in line with another recent publication which demonstrated a continuous decline of the ARI values from day 1 till 8 in patients with an unfavorable clinical outcome (mRS ˂3) in contrast to a continuous improvement of the ARI values in patients with a favorable clinical outcome (mRS ࣙ3).…”
Section: Discussionmentioning
confidence: 99%
“…The ability of the brain to regulate cerebral blood flow upon blood pressure variations has been described as cerebral pressure autoregulation (CA) . Previous data demonstrated an impairment of CA after aneurysmal subarachnoid hemorrhage (SAH) . Furthermore, it has been demonstrated that occurrence of an early disturbance of autoregulation after SAH is associated with delayed cerebral ischemia (DCI) .…”
Section: Introductionmentioning
confidence: 99%
“…1 Previous data demonstrated an impairment of CA after aneurysmal subarachnoid hemorrhage (SAH). [2][3][4][5] Furthermore, it has been demonstrated that occurrence of an early disturbance of autoregulation after SAH is associated with delayed cerebral ischemia (DCI). 6,7 In order to quantify the degree and time course of CA disturbances, multiple measurement methods have been established.…”
The results demonstrate the capability of the ARI to serve as a reliable early warning system after SAH. Further trials with larger study populations are needed to validate these promising preliminary data.
“…Some have reported that clotted blood and fluid buildup in the subarachnoid space increase ICP, whereas others have reported that blockage of the normal CSF circulation causes enlargement of the ventricles and elevation of ICP [1,3]. Furthermore, recent studies have shown that cerebral vasospasm following aSAH plays an important role in the elevation of ICP [19][20][21]. However, whether the accumulation of subarachnoid hemorrhage causes an increase in ICP has yet to be determined.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.